Skip to main content

Table 1 Clinical characteristics of the patients with NSCLC analyzed in the study

From: Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China

Parameters

Discovery cohort (N = 194)

Validation cohort (N = 172)

Independent cohort (N = 73)

Age (X ± SD)

59.2 ± 10.1

59.8 ± 10.2

57.6 ± 9.1

Gender

 Male

144 (74.2%)

136 (79.1%)

52 (71.2%)

 Female

50 (25.8%)

36 (20.9%)

21 (28.8%)

TNM stage

 I

87 (44.8%)

74 (43.0%)

23 (31.5%)

 II

32 (16.5%)

34 (19.8%)

20 (27.4%)

 III

75 (38.7%)

64 (37.2%)

30 (41.1%)

Histological type

 ADC

95 (49.0%)

89 (51.7%)

47 (64.4%)

 SCC

88 (45.3%)

76 (44.2%)

26 (35.6%)

 ADC/SCC

11 (5.7%)

7 (4.1%)

0 (0.0%)

Tumor size (cm)

 < 5

108 (55.7%)

97 (56.4%)

31 (42.5%)

 ≥ 5

86 (44.3%)

75 (43.6%)

42 (57.5%)

Differentiation

 Well/moderate

126 (64.9%)

105 (61.0%)

43 (58.9%)

 Poor

68 (35.1%)

67 (39.0%)

30 (41.1%)

Lymphatic metastasis

 No

105 (54.1%)

81 (47.1%)

45 (61.6%)

 Yes

89 (45.9%)

91 (52.9%)

28 (38.4%)

Follow-up time (month)

 Median (IQR)

37 (24-62)

36 (23-54%)

22 (14-35)

Smoking history

 No

79 (40.7%)

62 (36.0%)

33 (45.2%)

 Yes

115 (59.3%)

110 (64.0%)

40 (44.8%)

Family cancer history

 No

161 (83.0%)

151 (87.8%)

71 (97.3%)

 Yes

33 (17.0%)

21 (12.2%)

2 (2.7%)

  1. SD standard deviation, ADC adenocarcinoma, SCC squamous cell carcinoma, IQR inter-quartile range